share_log

和鉑醫藥-B：內幕消息 -有關與CULLINAN THERAPEUTICS, INC.就HBM7008合作的進展

HBM HOLDINGS-B: INSIDE INFORMATION -UPDATE ON COLLABORATIONWITH CULLINAN THERAPEUTICS, INC. FOR HBM7008

HKEX ·  Aug 8 19:24

Summary by Futu AI

和鉑醫藥-B（02142.HK）於2024年8月8日宣佈，根據與Cullinan Therapeutics, Inc.（「Cullinan」）就HBM7008藥物合作的協議，Cullinan已決定終止該協議，該終止將於2024年11月3日生效。和鉑醫藥-B將重新取得HBM7008的全球權利，並將繼續尋找其他開發及商業化的機會。公司提醒股東及潛在投資者，不保證最終能成功開發及銷售HBM7008，並建議投資者買賣股份時應審慎行事。
和鉑醫藥-B（02142.HK）於2024年8月8日宣佈，根據與Cullinan Therapeutics, Inc.（「Cullinan」）就HBM7008藥物合作的協議，Cullinan已決定終止該協議，該終止將於2024年11月3日生效。和鉑醫藥-B將重新取得HBM7008的全球權利，並將繼續尋找其他開發及商業化的機會。公司提醒股東及潛在投資者，不保證最終能成功開發及銷售HBM7008，並建議投資者買賣股份時應審慎行事。
On August 8, 2024, Hutchison Pharma-B (02142.HK) announced that Cullinan Therapeutics, Inc. ('Cullinan') had decided to terminate the agreement on HBM7008 drug cooperation, and the termination will be effective on November 3, 2024. Hutchison Pharma-B will regain the global rights of HBM7008 and will continue to look for other opportunities for development and commercialization. The company reminds shareholders and potential investors that there is no guarantee of successful development and sales of HBM7008, and advises investors to act prudently when buying and selling shares.
On August 8, 2024, Hutchison Pharma-B (02142.HK) announced that Cullinan Therapeutics, Inc. ('Cullinan') had decided to terminate the agreement on HBM7008 drug cooperation, and the termination will be effective on November 3, 2024. Hutchison Pharma-B will regain the global rights of HBM7008 and will continue to look for other opportunities for development and commercialization. The company reminds shareholders and potential investors that there is no guarantee of successful development and sales of HBM7008, and advises investors to act prudently when buying and selling shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated